Long term safety and efficacy study of teriflunomide 7 mg or 14 mg in patients with relapsing-remitting multiple sclerosis ClinicalTrials.gov, 31 Mar 2011 Accessed on 5 Jan 2012 from http://clinicaltrials.gov/ct2/show/NCT00803049. CommentRecommendBookmarkWatch